UK confirms launch of new trial for Remdesivir in coronavirus Ruchika Sharma27 May 2020 1:17 PM ISTLondon: The UK government on Tuesday confirmed the launch of a new trial for selected coronavirus patients of remdesivir, a drug which is believed to...
Remdesivir shortens recovery time in COVID-19 patients, finds NEJM study Dr. Kamal Kant Kohli26 May 2020 6:46 AM ISTPreliminary results regarding the use of remdesivir against COVID-19 published in the New England Journal of Medicine reveal that Remdesivir was...
Cipla, Hetero approach DCGI seeking waiver of Clinical Trial of Remdesivir in India: Report MD Bureau25 May 2020 4:59 PM ISTNew Delhi: With pharma companies across the country making efforts to get the first-mover advantage in bringing potential coronavirus treatments, two...
Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir Ruchika Sharma15 May 2020 9:00 AM ISTHealth access groups say the pacts mean cheaper forms of the drug may not become available in nations seen as non-profitable to the five drugmakers
Hetero ties up with Gilead for Remdesivir Ruchika Sharma14 May 2020 12:16 PM ISTHetero will be supplying Remdesivir in 127 countries, including India, subject to regulatory approvals in respective countries
EMA recommends expanded use of remdesivir on compassionate grounds Dr. Kamal Kant Kohli13 May 2020 11:29 PM ISTThe European Medicines Agency (EMA) has recommended for wider and expanded compassionate use of investigational drug remdesivir to treat coronavirus...
Cipla becomes 2nd firm to enter tie-up with Gilead to make remdesivir in India MD Bureau13 May 2020 9:23 AM ISTCipla will be permitted to manufacture the active pharmaceutical ingredient (API) and finished product, and market it in 127 countries including India...
Jubilant Life Sciences enters into Licensing Agreement with Gilead for Remdesivir, potential therapy for Covid-19 Ruchika Sharma13 May 2020 9:15 AM ISTNoida: Jubilant Life Sciences Limited has announced that its subsidiary, Jubilant Generics Limited, has entered into a non-exclusive Licensing...
Gilead Sciences unveils plans of expanding global supply of Investigational Antiviral Remdesivir Ruchika Sharma8 May 2020 9:55 AM ISTFoster City: Bagging the USFDA nod for Emergency Use Authorization for remdesivir, maker Gilead sciences, recently announced its plans to increase its...
Health Ministry examining Remdesivir, minister cites Confusion over price and patent MD Bureau4 May 2020 11:03 PM ISTNew Delhi: Union Health Minister Harsh Vardhan on Monday said that there is a confusion over pricing and patent of experimental anti-viral drug...
US OKAY to treat seriously ill COVID-19 patients with Remdesivir MD Bureau4 May 2020 10:01 AM IST"We are now firmly focused on getting this medicine to the most urgent patients," Gilead CEO Daniel O'Day told CBS News on Sunday.
FDA okays emergency use of remdesivir in severe cases of Covid 19 Dr. Kamal Kant Kohli2 May 2020 10:44 AM ISTThe US Food and drug administration has issued an emergency use authorization on for antiviral drug remdesivir for patients hospitalized with a...
